Cart

The shopping cart is empty

View courses and libraries and add them to the cart

{{item.title}} {{item.ceu}} hours {{item.price | currency}} {{ getItemDiscountedPrice(item.price, item.discountedAmount) | currency}} {{item.priceAdjusted | currency}}
Total {{totalCEUs}} hours  {{cart.total_amount | currency}}
Expired activity
Please go to the PowerPak homepage and select a course.

The Pursuit of Hepatitis C Elimination: How the Pharmacist Can Make a Difference
Part 1: The Pharmacist's Role in HCV Testing and Counseling—Reaching Patients With the Greatest Need

Jointly provided by Postgraduate Institute for Medicine and Integritas Communications.
acpeacpe

This activity is supported by an independent educational grant from Gilead Sciences, Inc.

Launch date

August 30, 2019

Expiration date

August 30, 2020

Target Audience

This activity is intended for clinical pharmacists involved in the care of patients with or at risk for hepatitis C virus (HCV) infection.

Goal Statement

This educational activity will address the pharmacist's critical role in HCV elimination, guideline-based HCV testing and identification of persons at risk, harm-reduction–informed patient education, and selected models for effective linkage to HCV treatment.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Demonstrate knowledge of HCV epidemiology and HCV elimination goals
  • Offer guideline-based HCV testing and identify people at risk for HCV infection
  • Provide patient-centered counseling regarding chronic HCV infection and the benefits of HCV cure

Faculty

Lucas Hill, PharmD, BCACP, AAHIVP
HIV/HCV Pharmacist Specialist
University of California San Diego Health System
San Diego, California

Susan Lee, PharmD, BCPS, CDE
Pharmacist Specialist
Sandra Atlas Bass Center for Liver Diseases and Transplantation
Northwell Health, Manhasset, New York
Clinical Faculty, New York State Department of Health AIDS Institute
Clinical Education Initiative
New York

Joint Accreditation Statement

jointly accredited by (ACCME)In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Integritas Communications. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – JA4008162-9999-19-888-H01-P)

This is a knowledge-based activity.

Estimated time to complete activity: 60 minutes

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

  • Lucas Hill, PharmD, BCACP, AAHIVP - Nothing to disclose.
  • Susan Lee, PharmD, BCPS, CDE - Nothing to disclose.

Planners and Managers

The PIM planners and managers have nothing to disclose. The Integritas Communications planners and managers, Jeanette Ruby, MD, and Jim Kappler, PhD, have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. PIM and Integritas Communications do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Instructions to Receive Credit

In order to receive credit, participants must complete the following:

  1. Read the educational objectives, accreditation information, and faculty disclosures at the beginning of this activity.
  2. Complete the Preactivity Questions.
  3. Read or review the activity content.
  4. Complete the Postactivity Test Questions and Evaluation.
  5. Achieve a grade of 70% on the Postactivity Test Questions and complete the Evaluation to receive credit.

Media

Internet

Computer System Requirements

PC
Microsoft Windows 2000 SE or above.
Internet Explorer (v5.5 or greater), or Firefox

MAC
MAC OS 10.2.8
Safari
Internet Explorer is not supported on the Macintosh.

PIM Contact Information

For information about the accreditation of this program, please contact PIM via e-mail at inquiries@pimed.com or at http://www.pimed.com/.